Oushadhi to produce cholesterol-busting drug

K. Santhosh

Thrissur: The State government-owned Pharmaceutical Corporation (Indian Medicines) Kerala Limited, Oushadhi, plans to produce a cholesterol-lowering drug. The drug in capsule form will reach the market in two months.

Oushadhi Panchakarma Hospital and Research Institute Superintendent K.S. Rajithan said the clinical trials of the drug yielded positive results. The hospital will start a department for cholesterol research on November 29.

Free of cost

The department will initially provide the drug free of cost to patients. Dr. Rejithan said the drug would reduce the risk of heart attack, progressive coronary artery disease and stroke.

“The prevalence rate of dyslipidaemia (abnormal concentration of lipids or lipoproteins in the blood) is high in India. Experts say that by 2020, heart disease will be the cause of nearly 42 per cent of deaths in the country. Compared with the people living in the West, young Indians face five to ten times higher rate of heart attack and death,” he said.

Oushadhi’s drug for dyslipidaemia includes Thippali (Piper longum), Kattuthippaliveru (Piper longum ssp), Kattumulakinveru (Piper chaba), Koduvelikkizhangu (Plumbago rosea), Chukku (Zingiber officinalis), Kadukka (Terminalia chebula), Thannikka (Terminalia bellirica), Nellikka (Phyllanthus embilica), Kariveppu (Murraya koenigii) and Veluthulli (Allium sativum).

“The drug has practically no side-effects. Its price will be lesser than that of similar drugs available in the market,” said Dr. Rajithan.

Recommended for you